CT-2584

DB13098InvestigationalSmall molecule

CT-2584 has been used in trials studying the treatment of Prostate Cancer.

Chemical structure of CT-2584
Formula / weight
C30H55N5O3 · 533.802 g/mol (avg)
Code names
CT-2584

Resolves to

Compound
UNII67E5N3R22HCAS166981-13-1ChEMBLCHEMBL4297274PubChem3081346
Structure
InChIKeyMZNMZWZGUGFQJP-UHFFFAOYSA-NSMILESCCCCCCCCCCCCNCC(O)CCCCCCCCCN1C(=O)N(C)C2=C(N(C)C=N2)C1=O
Targets
Q9Y5K3PCYT1B

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with CT-2584, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In